BioInformant

Your Global Leader in Stem Cell Market Research

You are here: Home / Archives for Stem Cells

Takara Bio Establishes Foothold in the Pluripotent Stem Cell Market

By 1 Comment

Takara Bio EuropeTakara Bio broke news that the Medical Products Agency (“MPA”), the Swedish national authority responsible for regulation of drug and medical products, granted the company a manufacturing license for derivation and banking of human embryonic stem (hES) cells to be produced under GMP conditions. The cells will be produced at Takara Bio’s manufacturing laboratory located in Göteborg, Sweden, within Takara Bio Europe’s facility.

The announcement caught my attention, because to the best of my knowledge, Takara Bio is the first company worldwide to offer this service for human ESCs.

Takara Bio’s Role with Human Pluripotent Stem Cells

The significance of this event is that Takara Bio is now capable of providing a safe, reliable source of hES cells for future cellular therapeutic development by sourcing starting material from FDA-compliant facilities according to FDA guidelines and leveraging its proprietary, feeder-free hES cell establishment method, which is animal- and human-component free. [Read more…]

Stem Cell Infusion: What to Expect

By 1 Comment

In recent years, stem cell infusion has become a breakthrough technology. There have been multiple medical leaders citing regenerative medicine as the way of the future. Stem cells obviate our need to patch up the body or create stopgap measures for systems that don’t work. They instead promise to replace organs and tissues that no longer function, essentially rebuilding the body from the inside out. Naturally, science has not progressed to the point of spreading this technology across the globe. However, the growing availability and efficacy of stem cell infusion indicate this isn’t far off, either. [Read more…]

The Future of Stem Cell Therapy as Treatment for Autism

By 2 Comments

Treatment for autism is an increasingly important pursuit, as the Center for Disease Control and Prevention (CDC) estimates:

  • 1 in 59 children has been identified with autism spectrum disorder (ASD) [Read article]
  • Autism occurs in all racial, ethnic, and socioeconomic groups. [Read article]
  • Studies in Asia, Europe, and North America have identified ASD to have a prevalence rate of between 1% and 2%. [Data table]

With autism spectrum disorder (ASD) affecting between 1-2% of the population, the condition is becoming of increasing importance and a treatment for autism is becoming a highly sought-after medical breakthrough. [Read more…]

Mogrify Raises $3.7M for Direct Cell Reprogramming and Appoints Dr. Disley CEO

By Leave a Comment

MogrifyMogrify (Cell Mogrify Ltd) is a private biotechnology company has developed a direct cellular conversion technology to allow for the transformation (transmogrification) of any mature human cell type into any other – without going through a pluripotent stem cell- or progenitor cell-state. [Read more…]

What is the difference between totipotent, pluripotent, and multipotent?

By Leave a Comment

A common question is, what is the difference between totipotent, pluripotent, and multipotent cells? The answer is simple. Totipotent stem cells are the most versatile stem cell type, because they are formed shortly after fertilization of an egg cell by a sperm cell. They can become all of the cells of the human body, as well as the cells of the embryo and developing fetus.

At about four days into development, these totipotent cells specialize slightly, becoming pluripotent stem cells. [Read more…]

BioInformant's World-Class Clients